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behalf of the Melbourne Diabetes Prevention Study research groupAbstract
Background: Many public health interventions based on apparently sound evidence from randomised controlled
trials encounter difficulties when being scaled up within health systems. Even under the best of circumstances,
implementation is exceedingly difficult. In this paper we will describe the implementation salvage experiences from
the Melbourne Diabetes Prevention Study, which is a randomised controlled trial of the effectiveness and
cost-effectiveness nested in the state-wide Life! Taking Action on Diabetes program in Victoria, Australia.
Discussion: The Melbourne Diabetes Prevention Study sits within an evolving larger scale implementation project,
the Life! program. Changes that occurred during the roll-out of that program had a direct impact on the process of
conducting this trial. The issues and methods of recovery the study team encountered were conceptualised using
an implementation salvage strategies framework. The specific issues the study team came across included
continuity of the state funding for Life! program and structural changes to the Life! program which consisted of
adjustments to eligibility criteria, referral processes, structure and content, as well as alternative program delivery for
different population groups. Staff turnover, recruitment problems, setting and venue concerns, availability of
potential participants and participant characteristics were also identified as evaluation roadblocks. Each issue and
corresponding salvage strategy is presented.
Summary: The experiences of conducting such a novel trial as the preliminary Melbourne Diabetes Prevention
Study have been invaluable. The lessons learnt and knowledge gained will inform the future execution of this trial
in the coming years. We anticipate that these results will also be beneficial to other researchers conducting similar
trials in the public health field. We recommend that researchers openly share their experiences, barriers and
challenges when conducting randomised controlled trials and implementation research. We encourage them to
describe the factors that may have inhibited or enhanced the desired outcomes so that the academic community
can learn and expand the research foundation of implementation salvage.
Keywords: Implementation, Salvage strategy, Type 2 diabetes, Prevention, Effectiveness, Randomised controlled trialBackground
Traditionally randomised controlled trials (RCTs) are
scientific experiments that utilise controlled environ-
ments to allocate a treatment to the intervention group,
while the control group receives a placebo or no treat-
ment at all [1]. RCTs are considered to be the most reli-
able method for gathering evidence about the efficacy of* Correspondence: director@greaterhealth.org
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reproduction in any medium, provided the orpublic health interventions, as they uphold high stan-
dards of internal validity inherent in their methodo-
logical design [1-3]. Internal validity is defined as the
extent to which the independent variable (health inter-
vention; drug trial or lifestyle changes program) pro-
duces the desired effect or outcome [4]. Although RCTs
provide reliable evidence about the efficacy of an inter-
vention, they lack the ability to examine external validity
which ascertains whether the results or effects seen in a
small population can be expanded to or generalised to
other populations or settings [4]. External validity is aLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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real world [2].
The primary reason for conducting RCTs of public
health interventions is to translate them into scaled up,
system-wide programs [5]. A missing link between science
and practice called implementation science or research
has emerged through studying the process of implement-
ing evidence-based programs and practices in the real
world [6-8]. Implementation research is the study of
methods to promote the systematic uptake of research
findings and other evidence-based practices into routine
practice, to improve the quality and effectiveness of health
services [9]. It includes the study of influences on health-
care professionals and organisational behaviour including
processes, barriers and facilitators [9].
Many policies based on apparently sound evidence from
RCTs encounter difficulties when being scaled up within
health systems. Even under the best circumstances, imple-
mentation is exceedingly difficult. The road is likely to be
full of unexpected detours, blind alleys, new opportunities
and changing constraints. These constraints may vary over
time leading to a trial and error approach to discover feas-
ible solutions [10].
Not as well discussed in the literature is the process of
evaluating an RCT alongside an already established and
operational health intervention or program occurring in
a real world, primary or community health care setting.
We did not find any evidence in the literature of this
particular evaluation methodology or the specific pro-
blems or issues that may be encountered when embark-
ing on such an evaluation.
Implementation Salvage Strategies is a framework pro-
posed by Hoagwood et al. (2011) to describe and under-
stand the possible factors that can influence the conduct
of a trial within real world circumstances and the pos-
sible solutions to such problems [11]. This model high-
lights specific factors that can impede on different
phases of a trial, and is used to analyse, describe and
promote strategies to rescue a study where it otherwise
might be terminated.
In this paper we will describe the implementation sal-
vage experiences for the Melbourne Diabetes Prevention
Study (MDPS), which is an RCT of the effectiveness and
cost-effectiveness nested within the Life! Taking Action
on Diabetes program (Life!) conducted in Victoria,
Australia. This state-wide type 2 diabetes prevention
program for high risk individuals is funded by the
Victorian Government Department of Health Victoria
and delivered by Diabetes Australia – Victoria (DA–
Vic), a non-government organisation (NGO), peak con-
sumer body and leading charity representing all people
affected by diabetes and those at risk.
We now describe how the need for adjustments to the
real world Life! program created challenges for thenested RCT and our implementation salvage for the
MDPS.
Context
Diabetes prevention
It was estimated that approximately 366 million adults,
8.3% of the adult population worldwide, had diabetes in
2011. This is expected to increase to 552 million adults,
9.9% of the expected population worldwide by 2030 [12].
These alarming statistics provide evidence for the need
to prevent type 2 diabetes (T2D). Several recent clinical
trials have demonstrated that lifestyle modifications with
weight loss combined with dietary change and moderate
exercise can reduce the incidence of T2D by up to 58%
for people at high risk [13-15]. Indeed, these have been
shown to be even more effective than drug treatment in
clinical trials, and have a prolonged impact [13,16,17].
The challenge has been to translate these findings into
the real world.
Encouraging results from small efficacy evaluative
trials conducted in the US, Finland and our own Greater
Green Triangle Diabetes Prevention Program (GGT
DPP) in Australia, have contributed to an emerging evi-
dence base in this field [18-20]. While there have been
some positive results and lessons learnt about preventing
diabetes in the real world, there were limitations in these
studies. The samples were in some cases self-selected,
were often small, some lacking a formal comparison
group (control), and follow-up was generally short with
the intervention remaining relatively intensive [21].
Understanding how to implement interventions on a
large-scale is the next step in the process of translating
diabetes prevention into multiple and multi-level popu-
lation strategies that span the state or national stage
[22]. There have been reported accounts in the literature
of the challenges of translating clinical trials into effect-
ive population programmes, along with the development
of recommendations and guidelines for prevention of
type 2 diabetes [23,24]. These frameworks are useful for
evaluation and implementation processes. In addition
more research is required to understand the effective-
ness of interventions, their acceptability, uptake, reach,
cost and how they work in different population sub-
groups and via which mechanisms. This is particularly
important for public health research, practice and policy
[21]. Evaluations of this nature can determine program
intensity, fidelity and sustainability in the long term.
Finland was the first country to undertake a large-scale
diabetes prevention intervention. The national Develop-
ment Programme for the Prevention and Care of Diabetes
(DEHKO 2000–2010) was the first of its kind aiming to
improve the quality of diabetes care, the support for self-
care and the prevention of T2D and its complications
[25]. One of the three main goals was to develop a
Dunbar et al. BMC Public Health 2012, 12:806 Page 3 of 9
http://www.biomedcentral.com/1471-2458/12/806community-based high risk program in primary and occu-
pational care to prevent T2D, called the National Type 2
Diabetes Prevention Programme in Finland: FIN-D2D
[26]. Other large scale diabetes prevention projects in-
clude the Diabetes in Europe – Prevention using Lifestyle,
Physical Activity and Nutritional Intervention (DE-PLAN
study) across Europe [27], and the Life! Taking Action on
Diabetes program (Life!) in the Australian state of Victoria
[28,29].
Life! taking action on diabetes program
Life! is a state-wide, group based, lifestyle change pro-
gram with the aim of targeting Victorians aged 50 years
or over at high risk of developing T2D. The goals of the
program are based on modifications to diet and physical
activity. The program is conducted by Life! facilitators
who are certified health professionals. Life! has direct
lineage from the Finnish Diabetes Prevention Study
(DPS) [15], the Good Ageing in Lahti region (GOAL)
Implementation trial [18] and is the scaled-up version of
the GGT DPP [20]. In addition, the Victorian Govern-
ment’s Healthy Living Course randomised controlled
trial in 2005 examined the feasibility of a six session
group-based lifestyle intervention in a Victorian popula-
tion [30], which also informed the development of the
Life! program. The Life! program optimises intervention
fidelity through a rigorous annual training and accredit-
ation program for facilitators [31].
The Melbourne diabetes prevention study (MDPS)
The Melbourne Diabetes Prevention Study (MDPS) is a
research project set up to study in detail a cohort of
individuals undertaking the Life! program in order to
evaluate the effectiveness of a large-scale prevention pro-
gram, and importantly the cost-effectiveness. There is a
paucity of data to assess the long-term clinical and eco-
nomic impact of diabetes prevention programs. While
there have been some modelling studies that have deter-
mined that lifestyle intervention is cost-effective for
those with impaired glucose regulation [32,33], uncer-
tainties exist about model parameters, real costs and
benefits of screening, and practical considerations about
the affordability, acceptability and feasibility of interven-
tions [21,32-34].
The MDPS is an RCT which aims to evaluate the effi-
cacy and effectiveness of Life! by monitoring partici-
pants’ clinical and behavioural outcomes before and after
the Life! intervention, as previously reported [35]. An
economic assessment of Life! is also included in the
MDPS to determine its ‘value-for-money’. The MDPS
also provides the opportunity to utilise implementation
research methodology to examine the process of imple-
menting an evidence-based diabetes prevention program
in the real world.In brief, the MDPS intends to recruit 796 partici-
pants for this open randomised clinical trial, 398 will
be allocated to the intervention arm and 398 to the
usual care arm. Several methods of recruitment will be
used in order to maximise the number of participants.
Individuals aged 50 to 75 years will be screened with a
risk tool (AUSDRISK[36]) to detect those at high risk
of developing T2D. Those with existing diabetes will
be excluded. Intervention participants will undergo an-
thropometric and laboratory tests, and comprehensive
surveys at baseline, at three months (following the
main part of the intervention) and 12 months, while
control participants will undergo testing at baseline
and 12 months only.
The intervention consists of an initial individual session
followed by a series of five structured-group sessions. The
first four group sessions will be carried out at two week
intervals and the fifth session will occur eight months after
the first group session. The intervention is based on the
Health Action Process Approach (HAPA) model [37-39]
and sessions empower and enable participants to follow
the five goals of the Life! program. The intervention fidel-
ity is maintained through a thorough accreditation and
training process for facilitators as outlined above. It is also
achieved through employing a single facilitator to run all
of the MDPS groups. This minimises the variability in
course delivery and content participants will receive.
The primary outcomes under investigation are changes
in diabetes and cardiovascular disease (CVD) risk as
determined by changes in weight, waist circumference,
fasting plasma and 2 h glucose, blood pressure and lipids
at the baseline, 3 and 12 month assessments. The reduc-
tion in diabetes risk is calculated from the reduction in
weight and waist circumference and the reduction in
cardiovascular risk from changes to the Framingham risk
score which incorporates the changes in the individual
risk factors. Secondary outcomes consist of changes in
psychosocial and quality of life measurements.
Discussion
Evaluation roadblocks
Encountering unexpected problems while conducting
clinical trials is an inherent part of research, as discussed
in detail by many authors [1,40-45]. Translating evidence-
based practices and process from RCTs to large-scale im-
plementation projects can be an even bigger test, and
evaluation of the effectiveness of such projects can be an
enormous task as public health interventions are often
complex and difficult to evaluate. This evaluation is com-
plicated in the MDPS as it is an RCT being conducted
within an already established and operational, large-scale
health intervention program.
The MDPS intervention arm sits within an evolving lar-
ger scale implementation project, the Life! program.
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a direct impact on the process of conducting this trial.
Life! is an evolving and changing program that is subject
to modifications made at a political and environmental
level beyond the control of the MDPS researchers. The
nature of the Life! intervention was changing over time.
This custom-tailoring of the Life! program was essential
for its progress and success, and to assist with community
engagement, promoting risk assessment, program entry,
and sustainability. Such changes have implications on the
fidelity and usefulness of the MDPS.
Life! was initiated in 2007, with the MDPS starting ap-
proximately 15 months later. From inception of the Life!
program until 2010 numerous adjustments were made
to the eligibility criteria, referral process, structure and
content, as well as alternative program delivery for dif-
ferent population groups. These adjustments are out-
lined in detail below.
Ethics approval for the MDPS was obtained from
Deakin University Human Research Ethics Committee
(Project Code 2009–066).
Lessons learnt from MDPS
It was decided by the research team in 2009–10 to pause
the MDPS after a total of n = 92 individuals completed the
study and then to decide how to proceed further. This ini-
tial phase we now refer to as the preliminary MDPS study
(pMDPS) [35]. This situation arose due to difficulties with
recruiting participants into the RCT and due to uncertain-
ties about what version of the Life! intervention was actu-
ally being evaluated. This break has given the study team
the opportunity to reflect upon the study, to process the
available information, to report preliminary results [35],
and to learn from the experiences of undertaking imple-
mentation research in this ever changing context.
We have now started again and the new study called
MDPS is informed by the pMDPS experience. As there
were changes to the intervention and other things, the
pMDPS and MDPS and their participants are being trea-
ted as separate entities to avoid threats to internal valid-
ity in both studies.
The summary in Table 1, with a few key examples
explained in more detail below, outlines the issues the
study team encountered in the pMDPS and methods of
recovery that were and will be employed in the future
execution of the MDPS. Implementation salvage strat-
egies and techniques as discussed by Hoagwood et al.
(2011) were used as a basis for conceptualising the issues
and solutions outlined below [11].
Implementation salvage strategies
Issue: sample selection
Two major challenges of conducting an RCT are recruit-
ment and retention of participants. Inadequate recruitmentis deleterious to RCTs, with consequences being reduction
of power to detect intervention effects if target numbers
are not achieved, and/or protracted recruitment. Delays
may result which affect the generalisability of findings, and
increase costs due to extension of time, which can all lead
to premature termination of the trial [40,43,45]. Puffer and
Torgerson (2003) state that in a survey of studies con-
ducted from 2000–2001 approximately 60% of clinical
trials had failed to meet their intended recruitment target
or required time extensions to do so [46]. Furthermore,
evidence suggests that response rates can be as low as 1%
in intervention studies [41]. The success of clinical research
is dependent on recruitment and retention of study
participants.
As the MDPS aim is to evaluate the effectiveness and
cost-effectiveness of the Life! program, recruitment strat-
egies had to be concurrent with what was happening in
the real world. In addition to GP recruitment, program
referral occurred through accredited Life! Facilitators,
the local community, partner agencies, the general pub-
lic and the workplace. The political and environmental
context influenced recruitment strategies. One was Vic-
torian state-wide roll out of Life! which impacted on
specific areas of metropolitan Melbourne that were ori-
ginally reserved for MDPS recruitment only. This left
the MDPS to compete within its allocated recruitment
area with the Life! program. It is probable that when
competing side by side like this, potential participants
would prefer to enrol in the Life! program as they are
guaranteed to receive the intervention [47].
General Practitioners (GPs) were required to confirm
eligibility for the Life! program through completion of a
referral form that included biochemical and anthropo-
metric measures. Newly diagnosed T2D was a specific
exclusion criterion. During this process GPs may have
experienced some degree of ‘clinical equipoise’ [48]
whereby their preference was to enrol participants into
the Life! program over the MDPS as they wanted their
patients to receive and benefit from the intervention im-
mediately, believing that it would be ethically unjust not
to do so. Clinical equipoise has been demonstrated to
have a detrimental effect on recruitment [49]. When
clinicians are uncertain about a treatment or they believe
one treatment is more favourable than another, it can re-
sult in them not referring patients into trials where the
‘unfavoured or uncertain’ treatment is being studied
[48].
Salvage strategy
MDPS salvage strategies have centred on establishing a
systematic process for monitoring the success of recruit-
ment streams at regular intervals and adapting recruit-
ment activities accordingly. While the preliminary MDPS
demonstrated that direct community recruitment yielded
Table 1 Melbourne diabetes prevention study evaluation roadblocks and salvage strategies
MDPS evaluation
roadblock
Threat to trial
validity
Brief explanation Salvage strategy
Staff Logistical
implementation
issue
High turnover of staff in the initial stages
of conducting the trial led to lack of
communication, inconsistency in trial
management, inadequate resource
allocation, and time delays to recruit
participants.
• A strategic leadership and management role was
created to oversee the trial and provide an essential
link between external stakeholders and the study team.
• Effort and time was allocated to identify and employ a
study coordinator, who wasexperienced in research
coordination with a local knowledge of health care
organisations/referral pathways/the Life! Program and
who could successfully manage the trial.
Sample Selection Under-recruitment
and
contamination of
control group
Recruitment for MDPS had to replicate
what was happening in the real world.
Life! recruitment strategies included
referral sources such as the community.
This took away resources and time from
establishing relationships and
partnerships with local general practice
clinics and divisions.
• MDPS reallocated resources and effort to source
casual ‘recruiting’ staff and mobilize them to develop a
presence at local community organisations such as
health clubs/gymnasiums, pharmacies, local churches,
University of the Third Age campuses and community
fetes and expos.
Additionally, earlier than expected state
wide roll out of Life! meant that MDPS
had to compete with Life! providers for
participants.
• The study team closely monitors recruitment activities
and adapts and refines the recruitment processes at
regular intervals.
Setting Logistical and
procedural
implementation
issue
In order to conduct the trial research
staff needed a venue to perform clinical
tests and the group sessions. Venue hire
was expensive and general practice and
division staff, and Life! Providers were
not directly involved in the trial.
• The study team engaged front line agencies
(community venues and Life! providers) through
establishing a partnership agreement that outlines the
benefits for each party and the roles and
responsibilities expected throughout the duration of
the trial (including clear referral pathways to refer
patients to MDPS and provision of venues).
Recruitment Under-recruitment
and under-
estimation of
effectiveness,
After investigating the recruitment
profile of the regions targeted in this
study it was recognized that there is a
tight and not necessarily readily
accessible pool of potential participants
over the age of 50 at high risk of
diabetes (approximately 8,000 people
[60,61]). Therefore recruitment
procedures need to efficiently capture
and engage the population at risk.
• In addition to expanding recruitment sources from
the community, recruitment was also extended to
community pharmacies in the local area.
• Approaches to creating and maintain effective
collaborations and partnerships can be rolled out to
other divisions of general practices or community
health services throughout eastern metropolitan
Melbourne, as a method to increase the catchment
area of potential study participants.
Participant
characteristics
Selection bias Many factors influence recruitment at
the participant- level. These factors
include low perception of diabetes risk
[52] and low motivation to participate in
trials.
• Risk awareness increased through social media and
marketing from DA-Vic at a local level to promote the
Life! program.
• Promotional materials have been developed for the
study to engage health professionals, organisations and
the general public. These materials have utilised local
area facts to enhance personalisation of the program to
potential participants of the trial.
Continuity of State
funding for Life!
program
Logistical
implementation
issue
Life! was dependent on the State health
department’s continued funding beyond
the period 2007–11. This funding was
not automatically guaranteed. Therefore
MDPS was reliant on this funding as
well, which caused study delays whilst
waiting to receive confirmation about
ongoing funding.
Although in May 2011 Life! was granted further funding
for another four years, the MDPS research team
developed contingency plans during this time of
uncertainty that consisted of:
• Strengthening already established relationships with
partner organisation (DA-Vic) to mobilise strategic
advocacy for the program.
• Proposing to self-fund or source alternative funding to
run the intervention for trial participants.
Structural
changes to
Life!
Intervention
validity
Life! is a real world program that
continually changes and evolves
through time. This made it difficult to
accurately assess what was being
implemented in the real world and
therefore difficult to evaluate the
intervention effect.
• To maintain fidelity of the intervention, the MDPS
research team improved communication with DA-Vic
to have more input over what was being delivered to
trial participants. This included a partnership agreement
between local Life! providers who would run a
specified modified version of the Life! program for the
forthcoming MDPS.
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proach to recruitment in community and pharmacies has
refined this process and reduced the financial burden to
the study. The study team has broadened the geographic
area for recruitment, and has utilised health professionals
(such as Pharmacists) with current links to health care
agencies in these areas to act as recruiters for the study. In
addition, the study team has invested considerable time
and resources into enhancing GP recruitment through
educational seminars outlining the benefits of the MDPS,
the newly revised content and structure, and differences
between MDPS and the Life! program in order to prevent
further clinical equipoise from occurring.
Potential contamination of control participants by
them receiving the intervention (Life! program) is being
monitored and will be taken into account during the
analysis. Further analysis may also be undertaken to de-
termine if there are any effects of selection bias. This
will be done by comparisons between recruitment areas
and between groups with different patient characteristics
(such as motivation or perceived risk of diabetes) to see
if there are any substantial differences.Issue: recruitment
The MDPS utilised messages promoting free clinical
tests. Our observations indicated that this may not have
been an effective incentive to attract participants. This is
in contrast to literature from the US that suggests that
free health checks are an incentive to participate in clin-
ical trials [19,51]. This could be true in the US context
where health care is not free or is otherwise heavily sub-
sidized for most US citizens, unlike the universal health
care coverage provided in Australia.
Also the perceived importance of diabetes prevention
by the public is low. Berryman et al. (2009) have shown
that diabetes is not regarded as an issue of great concern
compared with other diseases, that perceived personal
risk of contracting diabetes is low, and the seriousness of
diabetes is underestimated because management appears
straightforward [52].
Changing attitudes towards diabetes and participation
in its prevention is difficult. Motivating individuals to at-
tend a diabetes prevention program and change lifestyle
behaviours requires more than an advertising message.
Recruitment strategies used in RCTs require personalisa-
tion of the risk message by a suitable health professional
as they are a trusted source of information and advice
[52], but GP involvement is time-consuming and im-
practical in some contexts [47,53]. Additionally, GPs
own beliefs relating to the efficacy, effectiveness and
side-effects of a program have been shown to influence
both doctor and patient screening and recruitment in
clinical trials [47,48].Salvage strategy
Although many of the participant characteristics that in-
fluence recruitment into clinical trials were outside of the
control of the study investigators, there are some ways to
overcome these challenges. Reallocating resources and ef-
fort to source ‘recruiting’ staff and mobilise them to de-
velop a presence at local community organisations such as
health clubs/gymnasiums, local churches, University of
the Third Age campuses and community fetes and expos
is a method to try and increase familiarity, trust and
knowledge of the study with community members. Re-
cruitment was also extended to community pharmacies in
the local area. Strengthening relationships with potential
participants is a method to reduce the barriers participants
encounter when receiving health advice from a non-
trusted source.
It has been demonstrated that strategies focusing on
increasing potential participants’ awareness of the health
problem, its impact on health, and their engagement in
the learning process may increase recruitment into trials
[40]. These points will be taken into account when tai-
loring how recruiters approach and explain the study to
potential participants in the community. The use of
AUSDRISK as a screening tool is an effective way to
personalise risk of T2D at an individual level, as demon-
strated in the GGT DPP efficacy trial [54]. The introduc-
tion of the new individual session for MDPS anticipated
in future for the Life! program should overcome some of
these difficulties.
Issue: structural changes to Life!
The Life! facilitator and participant workbooks were
adapted from the course content delivered in the GGT
DPP [20], GOAL Implementation Trial [18] and Finnish
DPS [15]. Originally the course consisted of six group ses-
sions that offered participants skills, knowledge, support
and advice needed to make lifestyle changes in order to
prevent T2D. The content of the course sessions were
developed using health psychology theories of health be-
haviour change [37-39,55,56] and the Health Action
Process Approach (HAPA) [38,57]. A trained facilitator
[58] conducted each of the six sessions, the first five over
three months and the final session at eight months. A
physiotherapist/exercise physiologist and dietitian co-
facilitated sessions three and four related to physical activ-
ity and nutrition respectively.
In early 2010, new participant manuals were intro-
duced to accommodate individuals from various cultur-
ally and linguistically diverse backgrounds and those
with low literacy levels. This new version included use of
more illustrations to convey messages and supplemen-
tary materials for specific cultural needs. Additionally a
more ‘streamlined’ approach was undertaken with regards
to the structure of the sessions, with some changes made
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curriculum. The dietitian and a physiotherapist/exercise
physiologist changed to co-facilitating sessions two and
four. This modification was made in response to requests
from participants to have dietary information appear earl-
ier in the course.
Originally individuals at high risk of developing T2D
aged 50 years or over were eligible for Life! High risk was
defined as scoring 15 or over on the AUSDRISK tool [36].
Those of Aboriginal or Torres Strait Islander (ATSI) des-
cent, aged 18 years and over with an AUDRISK score of
12 more were also eligible.
Eligibility criteria were revised in July 2010 to include
individuals aged 50 years or over at high risk of T2D,
who score 12 or more on the AUSDRISK, and addition-
ally, any individual over the age of 18, regardless of
AUSDRISK score, who were of ATSI descent or had pre-
viously been diagnosed with either gestational diabetes
mellitus or cardiovascular disease (specifically ischemic
heart disease). In addition, individuals who had received
an occupational health assessment [59], and had an
AUSDRISK score of 12 or more and aged 18–39 were
funded to participate in the Life! program from a separ-
ate source.Salvage strategy
Due to the numerous adjustments made to the eligibility
criteria, referral processes, structure and content as
described above, it was decided to make a small number
of modifications to the MDPS intervention, to ensure
consistency between the number of sessions offered to the
future MDPS participants, and the content within those
sessions. When re-started, MDPS will examine the version
of Life! that we anticipate will be implemented in 2012.
One of the major changes to the MDPS version of
Life! is that instead of running a six group-session pro-
gram, the MDPS version of Life! will be modified to con-
sist of an individual session at the beginning of the
intervention phase and five group sessions. This parallels
the Life! Program, which has a separately funded ‘first
visit’. Participants will still receive the intervention from
Facilitators employed or contracted through accredited
Life! providers using the current Life! materials and
manuals. It will be delivered using a standardised ap-
proach for all MDPS participants. To achieve this,
required partnership agreements between local service
providers of the Life! program and Life! facilitators were
created, and they will run the new agreed version of
MDPS. Approval for this was given by DA-Vic. It is
hoped that this approach can be rolled out as a success-
ful model to efficiently and systematically create partner-
ships with other sites who may be involved in the trial,
therefore becoming a multi-site trial.Although there were these changes to the Life! eligibil-
ity criteria, the MDPS research team decided to stay
with the original criteria of adults aged 50 years or over
with an AUSDRISK score of 15 or more, as this was
what the funding body had endorsed and would contrib-
ute information on the cost-effectiveness of alternate de-
sign options.
Discussion of salvage strategies
What roadblocks were identified before starting the MDPS?
Although the MDPS research team did not perform a
formal risk analysis, some potential roadblocks were
identified when designing the MDPS. These included
issues such as recruitment and dropout rates, and the
impact of these were based on previous experience of
implementing DPPs. Also, the issues surrounding usual
care and other potential government or community dia-
betes initiatives impacting on the study were outlined in
the study proposal and are monitored by the study now.
Monitoring occurs through policies and procedures to
identify potential roadblocks in the form of risk regis-
tries which are managed by the MDPS study board and
implementation team.
However, the nature of implementing prevention pro-
grams in the real world means that some of the road-
blocks could not be predicted at any early stage and the
study team had to deal with issues as they arose. Fur-
thermore, once the Life! program was implemented as
part of government policy, time pressures and program
momentum impacted on the ability to do a detailed risk
analysis.
Do the roadblocks identified relate to what others have
found?
The issues encountered when implementing the MDPS
are similar to those outlined by leaders in population
level diabetes prevention initiatives [23,24]. They argue
that in order for successful execution and sustainability
of large population wide diabetes prevention programs
consideration needs to be given to factors such as cost
and resources, expertise of the research and implemen-
tation team, effective participant screening and uptake of
the intervention, maintained investment from funding
sources, ensuring management systems are of high qual-
ity and results are disseminated and utilised in an
efficient way to all levels of government, the wider com-
munity and individuals.
Summary
The experiences of conducting such a novel trial as the
MDPS have been invaluable. Table 1 provides a full list
of barriers encountered in the implementation of the
MDPS and proposed solutions. The lessons learnt and
knowledge gained will inform the future execution of
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to contribute to the ongoing Life! program. We antici-
pate that these results will also be beneficial to other
researchers conducting similar trials in the public health
field. Like Vedelø (2011), we also recommend that
researchers openly share their experiences, barriers and
challenges when conducting RCTs and implementation
research [44]. We encourage them to describe the fac-
tors that may have inhibited or enhanced the desired
outcomes so that the academic community can learn
and expand the research foundation of implementation
salvage.
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